Cancer care costs have surged over recent decades due to advancements in medical technology, the introduction of new treatment modalities, and the increasing prevalence of the disease. Innovations such as immunotherapy and precision medicine have significantly improved patient outcomes but come with high price tags. Additionally, prolonged survival rates mean that patients often require extended treatment and follow-up care, further inflating overall costs.
